Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

2019

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, et al. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clin Cancer Res. 2019;25(1):43-51.
Hamid AA, Gray KP, Shaw G, Macconaill LE, Evan C, Bernard B, et al. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer. Eur Urol. 2019;76(1):89-97.
Prutsch N, Gurnhofer E, Suske T, Liang HC, Schlederer M, Roos S, et al. Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma. Leukemia. 2019;33(3):696-709.
Lohse I, Azzam DJ, Al-Ali H, Volmar C-, Brothers SP, Ince TA, et al. Ovarian Cancer Treatment Stratification Using Drug Sensitivity Testing. Anticancer Res. 2019;39(8):4023-4030.
Isharwal S, Hu W, Sarungbam J, Chen Y-, Gopalan A, Fine SW, et al. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder. J Pathol. 2019;248(3):260-265.
Zhang Y, Mun SR, Linares JF, Towers CG, Thorburn A, Diaz-Meco MT, et al. Mechanistic insight into the regulation of SQSTM1/p62. Autophagy. 2019;15(4):735-737.
Reina-Campos M, Linares JF, Duran A, Cordes T, L'Hermitte A, Badur MG, et al. Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer. Cancer Cell. 2019;35(3):385-400.e9.
Racine-Brzostek SE, Shi PA. Emerging roles of adjunct therapies in acquired thrombotic thrombocytopenia purpura. Transfusion. 2019;59(8):2496-2498.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700